Furthermore, the expression of the sigma-2 receptor varies across heterogeneous cell lines (Barg et al., 1994; John et al., 1998; John et al., 1999), and this inconsistency has also impeded consensus on the therapeutic potential of the sigma-2 receptor in depression, even for well-characterized ligands. Here, TMEM97 is linked to major depressive disorder.